0000899243-22-033551.txt : 20221013 0000899243-22-033551.hdr.sgml : 20221013 20221013160036 ACCESSION NUMBER: 0000899243-22-033551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221011 FILED AS OF DATE: 20221013 DATE AS OF CHANGE: 20221013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saunders Ninfa CENTRAL INDEX KEY: 0001815499 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 221309120 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-11 0 0001492674 T2 Biosystems, Inc. TTOO 0001815499 Saunders Ninfa 101 HARTWELL AVE LEXINGTON MA 02421 1 0 0 0 Restricted Stock Units 2022-10-11 4 A 0 115000 0.00 A Common Stock 115000 115000 D Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units vest in one installment on the earlier of (i) October 11, 2023 and (ii) the date of the next annual meeting of stockholders. /s/ John Sprague, Attorney-in-fact 2022-10-13